Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bufexamac (Bufexamic acid) is a COX inhibitor for IFN-α release with anti-inflammatory, analgesic, and antipyretic action.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
50 mg | 在庫あり | ¥ 8,500 | |||
100 mg | 在庫あり | ¥ 11,000 | |||
200 mg | 在庫あり | ¥ 14,500 | |||
500 mg | 在庫あり | ¥ 20,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 7,000 |
説明 | Bufexamac (Bufexamic acid) is a COX inhibitor for IFN-α release with anti-inflammatory, analgesic, and antipyretic action. |
ターゲット&IC50 | IFN-α:8.9 μM |
In vitro | Bufexamac is a specific inhibitor of class IIB histone deacetylases (HDAC6 and HDAC10). Treatment of peripheral blood mononuclear cells with bufexamac inhibits the secretion of IFN-α. [1] Bufexamac is a frequent and relevant contact sensitizer. Bufexamac is a non-steroidal anti-inflammatory drug. [2] |
別名 | Bufexamic acid |
分子量 | 223.27 |
分子式 | C12H17NO3 |
CAS No. | 2438-72-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 3 mg/mL (13.43 mM)
DMSO: 42 mg/mL (188.1 mM)
H2O: < 1 mg/mL (insoluble or slightly soluble)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bufexamac 2438-72-4 Chromatin/Epigenetic DNA Damage/DNA Repair Immunology/Inflammation Neuroscience COX HDAC Histone deacetylases inhibit Bufexamic acid Inhibitor inhibitor